Krka, d. d. (WSE:KRK)

Market Cap	20.98B
Revenue (ttm)	8.14B
Net Income (ttm)	1.54B
Shares Out	n/a
EPS (ttm)	49.99
PE Ratio	13.61
Forward PE	n/a
Dividend	32.10 (4.84%)
Ex-Dividend Date	Jul 23, 2024

Volume	42
Average Volume	106
Open	684.00
Previous Close	686.00
Day's Range	676.00 - 684.00
52-Week Range	506.00 - 714.00
Beta	0.53
RSI	58.08
Earnings Date	Jan 30, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company provides non-prescription products for oral cavity and pharynx; cough and cold; analge...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.

Financial numbers in EUR